In our study, we evaluated ccRCC tumor tissues by immunofluorescence staining of common EMT markers (CDH1, CK18, CK19, VIM, S100A4) and stratified patients to EMT positive and EMT negative groups. The gene discussed is KRT19; the disease is neoplasm.